HBGSA: Hydrogen Bond Graph with Self-Attention for Drug-Target Binding Affinity Prediction

arXiv cs.LG / 4/28/2026

📰 NewsModels & Research

Key Points

  • The article introduces HBGSA, a new hydrogen-bond-aware model for predicting drug–target binding affinity to speed up drug discovery by improving virtual screening prioritization.
  • HBGSA addresses limitations of prior approaches by explicitly encoding hydrogen-bond spatial geometry using graph neural networks enhanced with self-attention.
  • The method also improves training by using a Pearson-correlation-based loss to better capture the correlation between predictions and target affinities.
  • Experiments on PDBbind Core Set and CSAR-HiQ show HBGSA outperforms baseline methods and exhibits strong generalization, with ablation studies confirming the contributions of hydrogen-bond modeling and the correlation loss.

Abstract

Accurate prediction of drug-target binding affinity accelerates drug discovery by prioritizing compounds for experimental validation. Current methods face three limitations: sequence-based approaches discard spatial geometric constraints, structure-based methods fail to exploit hydrogen bond features, and conventional loss functions neglect prediction-target correlation, a key factor for identifying high-affinity compounds in virtual screening. We developed HBGSA (Hydrogen Bond Graph with Self-Attention), a 3.06M-parameter model that encodes hydrogen bond spatial features. HBGSA uses graph neural networks to model hydrogen bond spatial topology with self-attention enhancement and Pearson correlation loss. Experimental results on PDBbind Core Set and CSAR-HiQ dataset demonstrate that HBGSA outperforms baseline methods with strong generalization capability. Ablation studies confirm the effectiveness of hydrogen bond modeling and Pearson correlation loss.